With $5B in China sales, AstraZeneca doubles down on Chinese biopharma innovation

Amber Tong

Ayisha Sharma

News Reporter

CAMBRIDGE, UK — AstraZeneca said it will continue to be the conduit for sharing Chinese innovation with the rest of the world, but will establish a …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

With $5B in China sales, AstraZeneca doubles down on Chinese biopharma innovation

Amber Tong

Ayisha Sharma

News Reporter

Sign up to read this article for free.

Trump announces picks for FDA, CDC; Novartis seeks bolt-on deals, raises guidance; RFK Jr., Elon Musk may find ...

For CDC, Trump picks Dave Weldon, a former congressman who pushed for vaccine injury claims

Trump names Johns Hopkins researcher Marty Makary to lead the FDA; also names CDC, Surgeon General picks

FDA approves BridgeBio's heart disease drug, setting up competition with Pfizer, Alnylam

Sanofi introduces new 340B payment model — report

Are programs with compounded GLP-1s safe for your population?

With $5B in Chi­na sales, As­traZeneca dou­bles down on Chi­nese bio­phar­ma in­no­va­tion

News Reporter

Sign up to read this article for free.

With $5B in China sales, AstraZeneca doubles down on Chinese biopharma innovation